Hims & Hers

News

Stethoscope on a tablet with digital globe overlain

Novo Nordisk unleashes Wegovy telehealth blitz

Novo Nordisk has enlisted the aid of major telehealth companies as it tries to dominate the self-pay market for obesity drugs in the US.

News

Compounders cast adrift after semaglutide shortage ends

The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, ending sales of compounded forms.

News

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

Partnership for Safe Medicines claims the Hims & Hers ad for compounded weight-loss drug semaglutide, due to run during the Super Bowl, is "reckless."

Novo Nordisk unleashes Wegovy telehealth blitz

Compounders cast adrift after semaglutide shortage ends

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Editor's Picks